22:50:56 EDT Tue 18 Aug 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:HBP from 2025-08-19 to 2026-08-18 - 30 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2026-08-18 01:07C:HBPHelix BioPharma Corp (2)2.02News ReleaseHelix BioPharma appoints Loeffler as CMO
2026-08-14 17:39C:HBPHelix BioPharma Corp (2)1.87News ReleaseHelix BioPharma appoints Mehrling CEO
2026-06-30 17:15C:HBPHELIX BIOPHARMA CORP.1.45News ReleaseHelix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development
2026-06-12 18:15C:HBPHELIX BIOPHARMA CORP.1.58News ReleaseHelix Biopharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Nine-Month Periods Ended April 30, 2026
2026-06-12 17:08C:HBPHelix BioPharma Corp (2)1.58SEDAR Interim MD & ASEDAR Interim MD & A
2026-06-12 17:05C:HBPHelix BioPharma Corp (2)1.58SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-06-12 10:02C:HBPHelix BioPharma Corp (2)SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-06-03 17:15C:HBPHELIX BIOPHARMA CORP.1.58News ReleaseHelix BioPharma Corp. Announces Closing of Private Placement of Convertible Debentures
2026-05-22 17:32C:HBPHelix BioPharma Corp (2)1.63News ReleaseHelix BioPharma grants options to buy 1.29M shares
2026-05-13 16:15C:HBPHELIX BIOPHARMA CORP.1.60News ReleaseHelix Biopharma Corp. Announces Strategic Board and Governance Appointments to Support Financing and Nasdaq Uplisting Strategy
2026-03-16 17:42C:HBPHelix BioPharma Corp (2)SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-03-16 17:00C:HBPHELIX BIOPHARMA CORP.1.79News ReleaseHelix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026
2026-03-16 16:23C:HBPHelix BioPharma Corp (2)SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-03-16 16:23C:HBPHelix BioPharma Corp (2)SEDAR Interim MD & ASEDAR Interim MD & A
2026-02-24 09:00C:HBPHELIX BIOPHARMA CORP.2.00News ReleaseHelix BioPharma Corp. Announces Presentation at 16th Annual World ADC London
2026-02-05 16:30C:HBPHELIX BIOPHARMA CORP.1.83News ReleaseHelix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases
2026-01-30 18:03C:HBPHelix BioPharma Corp (2)2.03News ReleaseHelix BioPharma holders OK all business items at AGM
2025-12-15 17:30C:HBPHELIX BIOPHARMA CORP.2.05News ReleaseHelix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025
2025-12-12 16:25C:HBPHelix BioPharma Corp (2)2.04SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-12-12 16:25C:HBPHelix BioPharma Corp (2)2.04SEDAR Interim MD & ASEDAR Interim MD & A
2025-10-29 17:59C:HBPHelix BioPharma Corp (2)SEDAR MD & ASEDAR MD & A
2025-10-29 13:52C:HBPHelix BioPharma Corp (2)2.09SEDAR Annual Information FormSEDAR Annual Information Form
2025-10-29 12:45C:HBPHELIX BIOPHARMA CORP.2.09News ReleaseHelix BioPharma Corp. Announces Fiscal 2025 Year-End Results
2025-10-29 11:53C:HBPHelix BioPharma Corp (2)2.09SEDAR MD & ASEDAR MD & A
2025-10-29 11:48C:HBPHelix BioPharma Corp (2)2.09SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-10-06 21:39C:HBPHelix BioPharma Corp (2)5.31News ReleaseHelix BioPharma does not say why trading is up
2025-09-09 16:15C:HBPHELIX BIOPHARMA CORP.1.48News ReleaseHelix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
2025-09-09 12:00C:HBPHELIX BIOPHARMA CORP.1.45News ReleaseHelix BioPharma Announces Presentation at Q3 Investor Summit Virtual on 16 September 2025
2025-09-05 18:54C:HBPHelix BioPharma Corp (2)1.45News ReleaseHelix ends review, drops GEM equity facility plan
2025-08-22 18:27C:HBPHelix BioPharma Corp (2)1.35News ReleaseHelix BioPharma closes $1.66-million private placement